Overview

Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes

Status:
Completed
Trial end date:
2017-06-02
Target enrollment:
Participant gender:
Summary
This clinical trial aims to test whether glibenclamide is non-inferior to insulin for the treatment of gestational diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Glyburide
Insulin
Insulin, Globin Zinc